INSP - Inspire Medical Systems, Inc.
| Previous Close | 39.12 |
| Open | 39.22 |
| Bid | 33.75 x 1100 |
| Ask | 0.00 x 1200 |
| Day's Range | 38.49 - 40.04 |
| 52 Week Range | 22.50 - 43.40 |
| Volume | 1,072,399 |
| Avg. Volume | 348,054 |
| Market Cap | 841.303M |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.13 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.60 |
- GlobeNewswire•16 days ago
Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results
MINNEAPOLIS, June 07, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- ACCESSWIRE•19 days ago
Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks
WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.
- GlobeNewswire•24 days ago
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
MINNEAPOLIS, May 30, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- Benzinga•25 days ago
Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation
Not a month into Inspire Medical Systems Inc (NYSE: INSP)’s life as a publicly traded company, the Street is coming to consensus. “We believe Inspire Medical Systems is well positioned to disrupt the obstructive sleep apnea market over the next several years,” Block said in a note.
- InvestorPlace•last month
3 New Healthcare Stocks to Buy Right Now
As we continue to age and populations grow, demand for new and innovative healthcare solutions is only growing as well. Already preliminary data shows that MOR208 could be a better therapy than the so-called cell therapies when used in combination to cure cancer.
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the closing of its initial public offering of 7,762,500 shares of its common stock at a public offering price of $16.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,012,500 additional shares. BofA Merrill Lynch and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. Guggenheim Securities, Stifel and Wells Fargo Securities acted as co-managers for the offering.
- Benzinga•2 months ago
Inspire Medical Systems Goes Public
The medical technology company Inspire Medical Systems, Inc. (NYSE: INSP ) went public Thursday on the New York Stock Exchange. What Happened The company issued 6.75 million shares priced at $16 each. ...
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. Announces Pricing of Initial Public Offering
Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of its initial public offering of 6,750,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Inspire. In addition, Inspire has granted the underwriters a 30-day option to purchase up to 1,012,500 additional shares of its common stock at the initial public offering price, less underwriting discounts and commissions.
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. Announces Commencement of its Initial Public Offering
Inspire Medical Systems, Inc. (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that it has commenced an initial public offering of 5,000,000 shares of its common stock. Inspire also expects to grant the underwriters a 30-day option to purchase an additional 750,000 shares of its common stock. The initial public offering price is expected to be between $14.00 and $16.00 per share.
